	Immune checkpoint inhibitors-induced thyroid dysfunction improves the prognosis of patients with lung cancer: a meta-analysis and systematic review. Front Endocrinol (Lausanne) Dong Y, Li Y, Peng X, Fang W. PMID: 41641031 [PubMed - indexed for MEDLINE]
	Deep Learning Reconstruction Enhances Lung Cancer CT Imaging. Cureus Osaki T, Tamura A, Abe S, Yoshioka K. PMID: 41640929 [PubMed]
	Accuracy of mesothelioma occurrence forecasts, characteristics of cases, and incidence rates in Lombardy Region (Northern Italy). Epidemiol Prev Consonni D, Stella S, Dallari B, Binazzi A, Bonzini M, Mensi C. PMID: 41640317 [PubMed - indexed for MEDLINE]
	[Pleural mesothelioma due to asbestos exposure in operating room]. Epidemiol Prev Barbieri PG, Sarnico M, Paglierini P, Pezzotti C, Somigliana A. PMID: 41640316 [PubMed - indexed for MEDLINE]
	Plain language summary of TASUKI-52: A study looking at nivolumab plus platinum chemotherapy and bevacizumab as a combined treatment for people with advanced or recurrent nonsquamous non-small cell lung cancer (NSCLC). Future Oncol Sugawara S, Lee JS, Kang JH, Kim HR, Inui N, Hida T, Lee KH, Yoshida T, Tanaka H, Yang CT, Inoue T, Nishio M, Goto Y, Tamura T, Yamamoto N, Yu CJ, Akamatsu H, Takahashi S, Nakagawa K. PMID: 41640231 [PubMed - as supplied by publisher]
	Giant Cell Arteritis/Polymyalgia Rheumatica and Atypical Pulmonary Carcinoid Tumor: A Paraneoplastic Syndrome? Am J Case Rep Al Tabaa O, Hamroun S, Al Tabaa K, Poll R, Al Sheikh W, Pertuiset E. PMID: 41640080 [PubMed - indexed for MEDLINE]
	Phytochemical-Based Strategies for Lung Cancer: Clinical Insights Into Pleiotropic Molecular Signaling and Therapeutic Roles. Phytother Res Islam MR, Rauf A, Akter H, Al-Imran MIK, Fakir MNH, Thufa GK, Habiba U, Riya KN, Rahman MM, Hussain MS, Ogaly HA, Aljohani ASM, Al Abdulmonem W, Formanowicz D, Iriti M. PMID: 41640058 [PubMed - as supplied by publisher]
	Changes in premature mortality burden due to lung cancer attributable to tobacco exposure in rural southwest China: three repeated cross-sectional studies from 2013 to 2025. Arch Public Health Li GH, Bao QR, Shi RM, Gu F, Ma GY, Golden AR, Cai L. PMID: 41639920 [PubMed - as supplied by publisher]
	Neoadjuvant chemoimmunotherapy in non-small cell lung cancer: evolving resectability criteria, biomarker-driven postoperative management, and emerging therapeutic strategies. J Immunother Cancer Patel A, Wakeam E, Josephides E, Lampridis S, Karapanagiotou E, Middleton G, Naidu B, De Perrot M, Bille A. PMID: 41638870 [PubMed - indexed for MEDLINE]
	Primary uterine yolk sac tumour: a rare and aggressive malignancy - navigating diagnostic uncertainty and treatment pathway. BMJ Case Rep Natarajan J, Murali A, Radhakrishnan V, Raja A. PMID: 41638763 [PubMed - indexed for MEDLINE]
	Genomic Characterization of Lung Cancer in Never-Smokers Using Deep Learning. Mod Pathol Saha M, Tran TV, Bhawsar PMS, Zhang T, Zhao W, Hoang PH, Mutreja K, Lawrence SM, Rothman N, Lan Q, Homer R, Baine MK, Sholl LM, Joubert P, Leduc C, Travis WD, Chanock SJ, Shi J, Yang SR, Almeida JS, Landi MT. PMID: 41638573 [PubMed - as supplied by publisher]
	Clinical Progression Modes of Crizotinib Failure and Subsequent Management of Advanced Non-Small Cell Lung Cancer With ROS1 Rearrangement. Cancer Med Tan QQ, Chen YQ, Gao YE, Liu KJ, Mao ZJ, Zheng MY, Su JW, Yang J, Gao QY, Chen HJ, Yang JJ. PMID: 41638230 [PubMed - indexed for MEDLINE]
	Real-world evidence on diagnostic pathways and biopsy optimization for PD-L1 and molecular profiling in advanced non-small cell lung cancer: A four-year cohort analysis. J Bras Pneumol Rodrigues LV, Oliveira J, Duarte J, Taborda-Barata L, Sousa V, Cordovilla R. PMID: 41637367 [PubMed - indexed for MEDLINE]
	Lineage plasticity: a new dilemma in lung cancer treatment. Mol Biol Rep Huo C, Wang Y, Li R, Xie X, Lyu W, Chen D, Sun Y. PMID: 41636935 [PubMed - in process]
	Case report: Immune checkpoint inhibitor-induced fulminant diabetic ketoacidosis: a case-based review and considerations for immunotherapy discontinuation. Front Immunol Zhao S, Liu X, Tan P, Mu Y, Tan S, Hou A. PMID: 41635837 [PubMed - indexed for MEDLINE]
	Spotlights on ubiquitin-specific proteases in lung cancer: from multifaceted pathophysiological mechanisms to potential therapeutic targets. PeerJ Shen X, Wang R, Su F, Guo J, Zhao D, Yuan F, Zhang T, Hou X. PMID: 41635813 [PubMed - indexed for MEDLINE]
	Medical expenses and influencing factors in lung cancer patients: a comparative analysis between surgical and non-surgical cases from Xiamen, China. Front Public Health Chen L, Luo W, Liu J, Lin M, Zhuang Z. PMID: 41635439 [PubMed - indexed for MEDLINE]
	Prediction of non-small cell lung cancer subtypes is possible through restricted spectrum imaging. Front Oncol Shen L, Zhang Y, Huang Z, Dai B, Yang Y, Wang Z, Yu X, Meng N, Fu FF. PMID: 41635406 [PubMed]
	Comparison of the efficacy based on clinicopathological characteristics and the safety of first-line treatments for patients with advanced ALK rearrangement non-small cell lung cancer: a network meta-analysis. Front Oncol Li Y, Wen Y, Zhang W, Zhao Y, Zhou L, Zeng X, Kang X, Li L. PMID: 41635404 [PubMed]
	Dual-correction robotic bronchoscopy system with ultra-thin catheter for diagnosing challenging peripheral pulmonary nodules: A multi-centre prospective trial. Pulmonology You Z, Huang J, Wang F, Xu L, Liu J, Li H, Tang J, Li W, Li Z, Liu Y, Bai Y, Li S, Zhong C. PMID: 41635252 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 156109

Page 1 of 7806



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy